Fifteen days after the joint venture was signed, Zambia's cholera vaccine plant has a hole in the ground. Health Minister Roma Chilengi led a groundbreaking ceremony on Tuesday 17 November at the Lusaka South Multi-Facility Economic Zone, joined by Wang Sheng, minister counsellor at the Chinese embassy, senior officials and representatives of the Chinese partner, Xinhua reported from Lusaka. Zambia Monitor covered the minister's remarks the same day.

The plant belongs to ZAMVAX Limited, a joint venture in which the Industrial Development Corporation, the State's investment arm, holds 60 per cent and Jijia International Medical Technology Company of China 40 per cent. Its first phase is a fill-and-finish facility: bulk oral cholera vaccine will be imported and then filled, finished, packaged and quality-checked in Lusaka, with an annual target of up to 20 million doses. A second phase would produce the antigen locally, making the line a complete manufacturing operation, and the partners have spoken of expanding later into paediatric and animal vaccines. Neither Tuesday's reports gave a completion date or a cost; when the agreement was signed on 2 November, Ecofin Agency reported the first phase at US$24.13 million and the IDC's chief executive, Cornwell Muleya, put the whole two-phase project at about US$213 million, with the second phase dependent on financing, feasibility studies and regulatory approval.

Why the minister wants it

Chilengi, who reminded his audience that he is a professor of vaccinology, drew on the experience of the COVID-19 pandemic, when countries with their own vaccine production could respond to deaths at home while others waited. For public health security, he said, commodity sovereignty is not an option. Zambia keeps suffering cholera outbreaks although effective vaccines exist, he said, and making them locally would widen access. He thanked China for earlier donations of oral cholera vaccine and said the project fulfilled the President's vision of domestic vaccine manufacturing, according to Xinhua.

Nothing pleases me more than to see work in the vaccine space.
— Roma Chilengi, Minister of Health, at the ZAMVAX groundbreaking in Lusaka on 17 November, as reported by Zambia Monitor

Wang Sheng called the plant a milestone for Zambia's health sector, timely given cholera's persistence in Zambia and across Africa, and said it would reduce reliance on imported vaccines, save foreign exchange, cut costs and shorten supply chains, with the potential to make Zambia a regional supplier.

The outbreak the plant is too late for

The plant will not help with the outbreak now under way, which has been running since it was declared on 28 July. The Zambia National Public Health Institute's update of Monday 16 November, reported by Zambia Monitor, recorded 74 new cases and two deaths in 24 hours, taking the cumulative total to 3,099 cases, 437 of them laboratory-confirmed, and 68 deaths, with 2,930 patients recovered and discharged and 101 still in health facilities. The outbreak has reached 27 districts in seven provinces. Lusaka district accounts for 1,959 cases, almost two-thirds of the total, followed by Chibombo on 371, Chongwe on 158 and Chilanga on 130; Mpulungu, Chiengi and Mwansabombwe in the north each have between 86 and 90.

The outbreak at 16 November (ZNPHI)

  • 3,099 cumulative cases, 437 laboratory-confirmed; 68 deaths
  • 74 new cases and 2 deaths in the previous 24 hours
  • 27 districts in seven provinces; Lusaka 1,959, Chibombo 371, Chongwe 158, Chilanga 130
  • 2,930 recovered and discharged; 101 in health facilities
  • Outbreak declared 28 July 2026

The institute repeated its standing advice: wash hands with soap, drink boiled or treated water, cook food thoroughly and eat it hot, use and clean toilets, and go at once to the nearest health facility with watery diarrhoea or vomiting.

Sources: Zambia Monitor, “Zambia breaks ground on first cholera vaccine manufacturing plant” (17 Nov 2026); Xinhua, “Zambia breaks ground on first vaccine plant with Chinese partner” (18 Nov 2026); Ecofin Agency, “Zambia Plans $213 Million Cholera Vaccine Plant With Chinese Partner” (3 Nov 2026); Zambia Monitor, “Zambia cholera cases hit 3,099 as outbreak spreads to 27 districts” (16 Nov 2026).

Back to the front page